Cognetivity Financial Statements From 2010 to 2024
| CGNSF Stock | USD 0 0 42.86% |
Check Cognetivity Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cognetivity Neurosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Cognetivity financial statements analysis is a perfect complement when working with Cognetivity Neurosciences Valuation or Volatility modules.
Cognetivity |
Cognetivity Neurosciences Company Shares Outstanding Analysis
Cognetivity Neurosciences' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Cognetivity Neurosciences Shares Outstanding | 85.05 M |
Most of Cognetivity Neurosciences' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cognetivity Neurosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Cognetivity Neurosciences has 85.05 M of shares currently outstending. This is 52.89% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The shares outstanding for all United States stocks is 85.13% higher than that of the company.
Cognetivity Neurosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cognetivity Neurosciences's current stock value. Our valuation model uses many indicators to compare Cognetivity Neurosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cognetivity Neurosciences competition to find correlations between indicators driving Cognetivity Neurosciences's intrinsic value. More Info.Cognetivity Neurosciences is number one stock in return on equity category among its peers. It is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cognetivity Neurosciences' earnings, one of the primary drivers of an investment's value.About Cognetivity Neurosciences Financial Statements
Cognetivity Neurosciences stakeholders use historical fundamental indicators, such as Cognetivity Neurosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Cognetivity Neurosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cognetivity Neurosciences' assets and liabilities are reflected in the revenues and expenses on Cognetivity Neurosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cognetivity Neurosciences. Please read more on our technical analysis and fundamental analysis pages.
Cognetivity Neurosciences Ltd. operates as a healthcare company. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada. Cognetivity Neurosciences operates under Health Information Services classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Cognetivity Pink Sheet
Cognetivity Neurosciences financial ratios help investors to determine whether Cognetivity Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cognetivity with respect to the benefits of owning Cognetivity Neurosciences security.